Nanovesicles of nitrendipine with lipid complex for transdermal delivery: pharmacokinetic and pharmacodynamic studies

References

• Barry BW. 1987. Mode of action of permeation enhancers in human skin. J Control Release. 6:85–97.
   Google Scholar
• Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM. 2009. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 8:6.
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Krishna Mohan C, Lingam M, Prabhakar Reddy V, Venkateswarlu V, Madhusudan Rao Y. 2008. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization. Drug Dev Ind Pharm. 34:719–725.
   PubMed Web of Science ®Google Scholar
• Contreras MJF, Jim, enez Soriano MM, Di, eguez ARı. 2005. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharma. 297:134–145.
   PubMed Web of Science ®Google Scholar
• Cooper ER. 1984. Increased skin permeability for lipophilic molecules. J Pharm Sci. 73:1153–1156.
   PubMed Web of Science ®Google Scholar
• Cui F, Yang M, Jiang Y, Cun D, Lin W, Fan Y, Kawashima Y. 2003. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. J Control Release. 91:375–384.
   PubMed Web of Science ®Google Scholar
• Francoeur ML, Gloden GM, Potts PO. 1990. Oleic acid: its effects on stratum corneum in relation to (trans) dermal drug delivery. Pharm Res. 7:621–627.
   PubMed Web of Science ®Google Scholar
• Gannu R, Vishnu YV, Kishan V, Rao YM. 2007. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Curr Drug Deliv. 4:69–76.
   PubMedGoogle Scholar
• Gaur PK, Purohit S, Mishra S. 2013. Solid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug delivery. Biomed Res Int. 2013:10.
   Web of Science ®Google Scholar
• Gaur PK, Bajpai M, Mishra S, Verma A. 2014a. Development of ibuprofen nanoliposome for transdermal delivery: physical characterization, in vitro/in vivo studies, and anti-inflammatory activity. Artif Cells Nanomed Biotechnol. 1–6. DOI: https://doi.org/10.3109/21691401.2014.953631.
   Google Scholar
• Gaur PK, Mishra S, Kumar A, Panda BP. 2014b. Development and optimization of gastroretentive mucoadhesive microspheres of gabapentin by Box–Behnken design. Artif Cells Nanomed Biotechnol. 42:167–177.
   PubMed Web of Science ®Google Scholar
• Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A. 2014c. Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation. Drug Dev Ind Pharm. 40:568–576.
   PubMed Web of Science ®Google Scholar
• Gaur PK, Purohit S, Kumar Y, Mishra S, Bhandari A. 2014d. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery. Pharma Dev Technol. 19:48–54.
   PubMed Web of Science ®Google Scholar
• Giannakou SA, Dallas PP, Rekkas DM, Choulis NH. 1995. Development and in vitro evaluation of nitrendipine transdermal formulations using experimental design techniques. Int J Pharm. 125:7–15.
   Web of Science ®Google Scholar
• Ishida T, Takanashi Y, Doi H, Yamamoto I, Kiwada H. 2002. Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes. Int J Pharm. 232:59–67.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. 2007. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 335:167–175.
   PubMed Web of Science ®Google Scholar
• Maghraby GMME, Williams AC, Barry BW. 2000. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm. 204:159–169.
   PubMed Web of Science ®Google Scholar
• Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, Fadda AM. 2011. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. Eur J Pharm Biopharm. 78:27–35.
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. 2006. Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. J Drug Target. 14:632–645.
   PubMed Web of Science ®Google Scholar
• Mittal A, Sara US, Ali A, Mohammed A. 2009. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. Pharm Dev Technol. 14:422–434.
   PubMed Web of Science ®Google Scholar
• Ongpipattanakul B, Burnette R, Potts PO. 1991. Evidence that oleic acid exists as a separate phase within stratum corneum. Pharm Res. 8:350–354.
   PubMed Web of Science ®Google Scholar
• Patel NA, Patel NJ, Patel RP. 2009. Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol. 14:80–89.
   PubMed Web of Science ®Google Scholar
• Pierre MBR, Tedesco AC, Marchett JM, Vitória M, Bentley L. 2001. Stratum corneum lipids liposomes for the topical delivery of 5- aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol 1:5.
   PubMedGoogle Scholar
• Sinico C, Manconi M, Valenti M, Fadda AM. 2005. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release. 103:123–136.
   PubMed Web of Science ®Google Scholar
• Srisuk P, Thongnopnua P, Raktanonchai U, Kanokpanont. S. 2012. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm. 427:426–434.
   PubMed Web of Science ®Google Scholar
• Tipre DN, Vavia PR. 2003. Acrylate-based transdermal therapeutic system of nitrendipine. Drug Dev Ind Pharm. 29:71–78.
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Lukyanov AN, Klibanov AL, Omelyancnkod VG. 1992. Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. FEBS Lett. 305:185–188.
   PubMed Web of Science ®Google Scholar
• Touitou E, Godin B, Karl Y, Bujanover S, Becker Y. 2002. Oleic acid, a skin permeation enhancer, affects Langerhans cells and corneocytes. J Control Release. 80:1–7.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. 2010. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm. 383:1–6.
   PubMed Web of Science ®Google Scholar
• Wertz PW, Abraham W, Landmann L, Downing DT. 1986. Preparation of liposomes from stratum corneum lipids. J Invest Dermatol. 87:582–584.
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F. 2010. Preparation of stable nitrendipine nanosuspensions using the precipitation—ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm. Sci 40:325–334.
   PubMed Web of Science ®Google Scholar
• Yamane MA, Williams AC, Barry BW. 1995. Effects of terpenes and oleic acid as skin permeation enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int J Pharm. 116:237–251.
   Web of Science ®Google Scholar
• Yang M, Cui F, You B, Wang L, Yue P, Kawashima Y. 2004. A novel pH-dependent gradient-release delivery system for nitrendipine: II. Investigations of the factors affecting the release behaviors of the system. Int J Pharm. 286:99–109.
   PubMed Web of Science ®Google Scholar
• Zakir F, Vaidya B, Goyal AK, Malik B, Vyas SP. 2010. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv. 17:238–248.
   PubMed Web of Science ®Google Scholar